Scorpion Therapeutics
Director, Global Value & Access Strategy, povetacicept
Scorpion Therapeutics, Boston, Massachusetts, us, 02298
Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too!Try it now — JobsAI.
Role Summary
Director, Global Value Access & Strategy, povetacicept. Location: Boston, MA (3 days onsite, 2 days remote weekly). The role supports the asset with a primary focus on launch readiness for new indications and lifecycle management, responsible for global price & access strategy and value communications, and contributing to lifecycle strategy and cross-portfolio capability building. Responsibilities
Ensure launch readiness for new indication(s):
Partner cross-functionally and cross-Regionally to ensure robust, differentiated value proposition and integrated evidence plans to support global market access and value Develop the global pricing and market access strategy, payment models and negotiation approach Lead development of global strategic payer plan and prioritization in the evidence generation plan Drive delivery of unbranded, branded payer value communications and supportive training
Life-cycle management:
Partner cross functionally to shape LCM strategy, including indication sequencing Identify, prioritize and champion evidence required for access enabling trials and value optimization; determine minimum reimbursable profiles
Accountable for ensuring the market access and payer perspective is reflected in cross-functional strategies (e.g. commercial, product development, regulatory affairs) Collaborate closely with HEOR, regional market access, global commercial strategy, clinical development, medical affairs and corporate affairs counterparts to ensure value & access optimization Maintain industry awareness and proactively address changes in market trends, competition, product acceptance and new product releases and adjust market access plans accordingly Qualifications
8+ years of direct biotechnology / pharmaceutical industry experience and/or payer experience Deep working knowledge of both US and ex-US healthcare systems required; experience in comparable global and/or specialty disease area role considered a plus Demonstrated ability to think strategically and make sound pricing and market access recommendations Entrepreneurial, energetic, dynamic, enthusiastic, decisive, and self-motivated; possesses a sense of urgency with the ability to "make things happen" Strong practical, quantitative and analytical skills with understanding of pricing & reimbursement / HEOR principles General experience in commercialization and drug development Demonstrated ability to operate effectively within highly cross-functional teams in a matrix environment Outstanding written and oral communication skills; able to write and deliver presentations to professionals at all levels Strong relationship-building skills across geographies; team-oriented and reliable Demonstrates ethics and alignment with Vertex’s core values Education
BA/BS in a field requiring quantitative analysis; advanced degree preferred Skills
Strategic pricing and market access Global payer communications and evidence generation planning Cross-functional collaboration in a matrix organization HEOR principles and economic modeling
#J-18808-Ljbffr
Director, Global Value Access & Strategy, povetacicept. Location: Boston, MA (3 days onsite, 2 days remote weekly). The role supports the asset with a primary focus on launch readiness for new indications and lifecycle management, responsible for global price & access strategy and value communications, and contributing to lifecycle strategy and cross-portfolio capability building. Responsibilities
Ensure launch readiness for new indication(s):
Partner cross-functionally and cross-Regionally to ensure robust, differentiated value proposition and integrated evidence plans to support global market access and value Develop the global pricing and market access strategy, payment models and negotiation approach Lead development of global strategic payer plan and prioritization in the evidence generation plan Drive delivery of unbranded, branded payer value communications and supportive training
Life-cycle management:
Partner cross functionally to shape LCM strategy, including indication sequencing Identify, prioritize and champion evidence required for access enabling trials and value optimization; determine minimum reimbursable profiles
Accountable for ensuring the market access and payer perspective is reflected in cross-functional strategies (e.g. commercial, product development, regulatory affairs) Collaborate closely with HEOR, regional market access, global commercial strategy, clinical development, medical affairs and corporate affairs counterparts to ensure value & access optimization Maintain industry awareness and proactively address changes in market trends, competition, product acceptance and new product releases and adjust market access plans accordingly Qualifications
8+ years of direct biotechnology / pharmaceutical industry experience and/or payer experience Deep working knowledge of both US and ex-US healthcare systems required; experience in comparable global and/or specialty disease area role considered a plus Demonstrated ability to think strategically and make sound pricing and market access recommendations Entrepreneurial, energetic, dynamic, enthusiastic, decisive, and self-motivated; possesses a sense of urgency with the ability to "make things happen" Strong practical, quantitative and analytical skills with understanding of pricing & reimbursement / HEOR principles General experience in commercialization and drug development Demonstrated ability to operate effectively within highly cross-functional teams in a matrix environment Outstanding written and oral communication skills; able to write and deliver presentations to professionals at all levels Strong relationship-building skills across geographies; team-oriented and reliable Demonstrates ethics and alignment with Vertex’s core values Education
BA/BS in a field requiring quantitative analysis; advanced degree preferred Skills
Strategic pricing and market access Global payer communications and evidence generation planning Cross-functional collaboration in a matrix organization HEOR principles and economic modeling
#J-18808-Ljbffr